Working to facilitate rapid translation of scientific discoveries into therapeutics

Paul De Souza

PDS headshot cutted-3

Paul De Souza, PhD, MBBS

Paul de Souza’s laboratory interests include drug development, translational research, biomarkers for cancer treatments, angiogenesis, signal transduction, apoptosis, chemo-resistance, and the fundamental nature of synergy. These areas support his clinical research interests, which include Phase I-III clinical trials, and studies with pharmacokinetic or pharmacodynamic endpoints. His overarching aim is to find and support new treatments for cancer, using a rational and biological basis. His specific disease area interests include genitourinary and brain cancers.

2013-2021©European Society for Translational Medicine (EUSTM)